Events Search and Views Navigation
June 2013
DIA
“Progressive Patient Access (adaptive licensing) How could pilots look taking the new EU-PV legislation into account?”Dr. Anton (Tony) Hoos (GlaxoSmithKline)
Find out more »CancerRX Conference
(Chaired by Prof. Andrew Lo).Panel Discussants: New Business Models/NEWDIGS Gigi Hirsch (MIT) and Thomas Unger (Pfizer)
Find out more »September 2013
Special Executive Briefing on NEWDIGS/Adaptive Licensing Program (regulators-only)
Session Co-Leads: Gigi Hirsch and Ken Oye (MIT)
Find out more »IOM Roundtable on Value and Science-Driven Healthcare
Regulatory Science & Practice: Overview of Adaptive Licensing.Ed Pezalla (Aetna).
Find out more »November 2013
International Conference on Rare Diseases and Orphan Drugs (ICORD)
Controlled Early Access for Medicines to Patients with High Medical Need: What Can Adaptive Licensing Offer for Patients Suffering from Rare Diseases?(Abstract submitted by Tony Hoos/GSK).
Find out more »FasterCures 5th Annual Partnering for Cures
The Art and Science of Multi-stakeholder CollaborationPanelist: Gigi Hirsch.
Find out more »Alzheimer’s Disease and Dementia Initiative
New York Academy of Sciences.Panel: Public Private Partnerships. Panelist: Gigi Hirsch
Find out more »